IOL Chemicals & Pharmaceuticals Stock Screener | Share Price & Fundamental Analysis

Share Price NSE
₹73.32
▼ -0.95 (-1.28%)
2026-02-20 00:00:00
Share Price BSE
₹73.35
▼ -1.11 (-1.49%)
2026-02-20 00:00:00
Track IOL Chemicals & Pharmaceuticals share price live with TickJournal's free stock screener. Analyze IOL Chemicals & Pharmaceuticals share price history trends and compare 52-week high low levels. Calculate IOLCP stock fair value using fundamental analysis and view live share price charts. Determine IOL Chemicals & Pharmaceuticals share intrinsic value and compare it with current IOLCP share price. Record your IOL Chemicals & Pharmaceuticals trades in TickJournal's free trading journal and track your portfolio performance.
EPS (TTM) ₹3.44
Dividend Yield 1.07%
Debt to Equity 0.05
IOLCP 52 Week High ₹119.30
IOL Chemicals & Pharmaceuticals 52 Week Low ₹59.35
Operating Margin 12.00%
Profit Margin 5.83%
EBITDA ₹67.00
Net Income ₹31.00
Total Assets ₹2,382.00
Total Equity ₹1,688.00

IOL Chemicals & Pharmaceuticals Share Price History - Stock Screener Chart

Screen IOLCP historical share price movements with interactive charts. Analyze price trends and patterns.

IOL Chemicals & Pharmaceuticals Company Profile - Fundamental Screener

Screen IOL Chemicals & Pharmaceuticals company fundamentals and business profile. Use our stock screener to analyze sector, industry, and key company metrics for IOLCP shares.
Sector Healthcare
Industry Pharmaceuticals
Sub-Sector Pharmaceuticals
Segment E
ISIN INE485C01029

IOL Chemicals & Pharmaceuticals Balance Sheet Screener

Screen IOLCP balance sheet fundamentals including assets, liabilities, and equity. Use our screener tool to analyze financial health and share price valuation metrics.
Item 2025 2024 2023 2022
Assets
Total Assets 2,382 2,244 2,022 1,962
Current Assets 1,151 1,120 920 1,081
Fixed Assets 1,171 933 752 561
Liabilities
Total Liabilities 2,382 2,244 2,022 1,962
Current Liabilities 85 73 58 57
Non-Current Liabilities 0 0 0 0
Shareholders' Equity
Total Equity 1,688 1,612 1,508 1,392
Share Capital 59 59 59 59
Reserves & Surplus 1,629 1,553 1,449 1,334

IOL Chemicals & Pharmaceuticals Income Statement Screener - Profit & Revenue Analysis

Screen IOL Chemicals & Pharmaceuticals income statement and profit fundamentals. Analyze IOLCP quarterly results, revenue growth, EBITDA, net profit margins, and EPS using TickJournal's fundamental screener for IOL Chemicals & Pharmaceuticals share price evaluation.
Item 2025-Mar 2025-Jun 2025-Sept 2025-Dec 2024-Mar 2024-Jun 2024-Sept 2024-Dec 2023-Mar 2023-Jun 2023-Sept 2023-Dec 2022-Mar 2022-Jun 2022-Sept
Revenue 532 559 574 586 511 510 532 527 596 570 552 529 579 570 547
Expenses 465 490 511 534 454 451 484 476 492 491 481 476 527 509 510
EBITDA 67 70 64 51 57 59 48 51 104 80 71 53 52 61 37
Operating Profit % 12.00% 11.00% 10.00% 8.00% 10.00% 10.00% 8.00% 9.00% 16.00% 13.00% 12.00% 9.00% 8.00% 10.00% 6.00%
Depreciation 19 20 20 20 16 17 18 19 12 14 16 16 11 11 11
Interest 4 4 4 4 3 2 4 5 5 4 4 4 2 3 4
Profit Before Tax 45 46 41 28 37 40 26 28 87 61 51 32 39 47 22
Tax 13 12 11 7 10 10 7 7 22 15 13 9 9 12 6
Net Profit 31 34 30 21 28 30 19 21 65 46 38 23 30 35 16
EPS 1.07 1.16 1.02 0.70 4.71 5.11 3.26 3.50 11.03 7.81 6.45 3.93 5.07 5.91 2.71

IOL Chemicals & Pharmaceuticals Cash Flow Screener - Liquidity Fundamentals

Screen IOLCP cash flow statements and liquidity fundamentals. Analyze operating, investing, and financing activities using our stock screener for share price strength assessment.
Item 2025-March 2024-March 2023-March 2022-March
Operating Activities 179 290 122 93
Investing Activities -154 -191 -120 -121
Financing Activities 46 -93 -4 -2
Net Cash Flow 71 6 -2 -29

IOL Chemicals & Pharmaceuticals Shareholding Pattern Screener

See IOL Chemicals & Pharmaceuticals shareholding pattern with promoter, FII, and DII holdings. Check IOL Chemicals & Pharmaceuticals promoter holding and ownership changes for IOLCP on TickJournal.
Item 2025-Mar 2025-Jun 2025-Sept 2025-Dec 2024-Mar 2024-Jun 2024-Sept 2024-Dec
Promoter Holding 52.62% 52.62% 52.62% 52.62% 48.19% 48.19% 48.19% 52.62%
FII Holding 1.47% 2.59% 2.25% 2.08% 1.41% 1.39% 1.63% 1.49%
DII Holding 0.07% 0.02% 0.04% 0.03% 0.30% 0.10% 0.08% 0.08%
Govt Holding 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Public Holding 31.43% 30.22% 29.97% 30.51% 30.98% 31.48% 31.31% 31.23%
Other Holding 14.40% 14.54% 15.12% 14.76% 19.12% 18.84% 18.79% 14.58%
Shareholder Count 130,002 125,040 136,129 133,531 130,003 128,689 125,979 126,701

IOL Chemicals & Pharmaceuticals Share Dividend Screener - Share Yield Analysis

Check IOL Chemicals & Pharmaceuticals dividend history with payout and yield data. View IOL Chemicals & Pharmaceuticals dividend details including ex-dates and amounts for IOLCP stock.
Period Dividend Per Share Dividend Yield
2026-March ₹0.00 0.00%
2025-March ₹0.80 1.09%
2024-March ₹5.00 8.18%
2023-March ₹4.00 5.53%
2022-March ₹4.00 7.07%
2021-March ₹6.00 8.48%
2020-March ₹3.00 2.72%
2019-March ₹0.00 0.00%
2018-March ₹0.00 0.00%
2017-March ₹0.00 0.00%

IOL Chemicals & Pharmaceuticals Stock Index Membership

See which indices include IOL Chemicals & Pharmaceuticals stock. Check IOLCP index membership in NIFTY 50, SENSEX, and other indices on TickJournal.

IOL Chemicals & Pharmaceuticals Market Events Screener - Corporate Actions

Get IOL Chemicals & Pharmaceuticals corporate actions including splits, bonuses, and buybacks. Check IOL Chemicals & Pharmaceuticals stock events that may affect IOLCP share price.
Announcement Date Record Date Event Type Information Price Impact
Dividend ₹ 2.00 /share -22.67%
2026-02-17 2026-02-17 Dividend ₹ 1.00 /share -7.50%
2026-02-11 2026-02-11 Quarterly Result Announcement NA 12.36%
2025-11-11 2025-11-11 Quarterly Result Announcement NA -5.32%
2025-08-22 2025-08-22 Annual General Meeting NA 27.43%
2025-08-07 2025-08-07 Quarterly Result Announcement NA 0.92%
2025-05-16 2025-05-16 Quarterly Result Announcement NA 18.62%
2025-03-11 2024-12-27 Split 2:10 0.00%
2025-02-18 2025-02-18 Dividend ₹ 4.00 /share -7.33%
2025-02-12 2025-02-12 Quarterly Result Announcement NA 1.31%
2024-11-14 2024-11-14 Quarterly Result Announcement NA -6.34%
2024-08-23 2024-08-23 Annual General Meeting NA 24.87%
2024-02-16 2024-02-16 Dividend ₹ 5.00 /share -6.06%
2023-02-17 2023-02-17 Dividend ₹ 4.00 /share 1.13%
2022-02-15 2022-02-16 Dividend ₹ 4.00 /share -15.58%

IOL Chemicals & Pharmaceuticals Competitors Screener - Peer Comparison

Screen IOLCP competitors and compare share prices across peer stocks. Use our screener to analyze sector peers, fundamentals, and relative performance for better stock selection.
Company Market Cap P/E Ratio Revenue YoY Growth Net Profit RSI
Sun Pharmaceutical 413,741 37.53 54,729 9.71% 10,980 58.16
Divis Laboratories 167,006 67.40 9,712 18.67% 2,191 53.89
Torrent Pharmaceuticals 143,558 62.90 11,539 6.99% 1,911 66.58
Cipla 108,330 23.68 28,410 7.12% 5,291 43.41
Dr Reddys Laboratories 106,866 19.34 33,741 16.73% 5,725 60.10
Lupin 101,382 21.81 22,910 13.74% 3,306 57.52
Zydus Life Science 90,637 18.06 23,511 18.55% 4,615 49.52
Mankind Pharma 83,564 46.65 12,744 20.90% 2,007 38.95
Aurobindo Pharma 67,303 19.60 32,346 9.43% 3,484 47.48
Alkem Laboratories 64,469 26.53 13,458 3.70% 2,216 37.57

IOL Chemicals & Pharmaceuticals Company Announcements - News Screener

Screen IOLCP latest company announcements and news updates. Filter stock news, results, and material events using our screener for share price impact analysis.
Date Update Actions
2026-02-19 Announcement under Regulation 30 (LODR)-Newspaper Publication View
2026-02-19 Announcement under Regulation 30 (LODR)-Earnings Call Transcript View
2026-02-13 Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome View
2026-02-13 Intimation On Communication To Members Regarding Tax Deducted At Source For Interim Dividend View
2026-02-13 Announcement under Regulation 30 (LODR)-Newspaper Publication View
2026-02-13 Announcement under Regulation 30 (LODR)-Newspaper Publication View
2026-02-13 Announcement under Regulation 30 (LODR)-Investor Presentation View
2026-02-12 Announcement under Regulation 30 (LODR)-Press Release / Media Release View
2026-02-12 Corporate Action-Board approves Dividend View
2026-02-12 Board Meeting Outcome for Outcome Of The Board Meeting And Submission Of Un-Audited Financial Results For The Quarter And Nine Months Ended 31St December 2025 View
2026-02-12 Un-Audited Financial Results For The Quarter And Nine Months Ended 31St December 2025 View
2026-02-04 Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation View
2026-01-27 Disclosure Pursuant To Regulation 30 Of SEBI (Listing Obligations And Disclosure Requirements) Regulations 2015 View
2026-01-23 Board Meeting Intimation for Notice Of The Board Meeting View
2026-01-08 Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018 View
2025-12-29 Closure of Trading Window View
2025-12-05 EDQM Issued CEP Certificate For MINOXIDIL View
2025-11-26 Announcement under Regulation 30 (LODR)-Newspaper Publication View
2025-11-19 Announcement under Regulation 30 (LODR)-Earnings Call Transcript View
2025-11-13 Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome View